Monday, October 3, 2022

< + > From Lymphoma To Lupus And Beyond: The Remarkable Research Of CAR T Therapy

The first installment in a series that will explain a recent and revolutionary cell therapy called CAR T, delving into current successes and future opportunities.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > ŌURA Secures $200 Million in Series D Funding

Investments from Fidelity Management & Research Company and Dexcom Bring ŌURA Valuation to $5.2 Billion ŌURA , the company behind Oura ...